Axatilimab
Idiopathic Pulmonary Fibrosis
Clinical trials
2
Developer
Fred Hutchinson Cancer Center
Overview
Axatilimab is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 2 tracked IPF clinical trials.
Axatilimab clinical trials
Explore related
Medical disclaimer. This page summarizes research about Axatilimab for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.